Review
[Ovarian cancer from the standpoint of medical oncology]
[Article in
Japanese]
Affiliations
- PMID: 17637538
Item in Clipboard
Review
[Ovarian cancer from the standpoint of medical oncology]
[Article in
Japanese]
Gan To Kagaku Ryoho.
2007 Jul.
Abstract
Ovarian cancer is chemosensitive. Staging surgery followed by the first line chemotherapy is recommended no matter the stage. For recurrent disease, it is difficult to prolong the survival by chemotherapy. The goal is palliation. When primary debulking surgery can not be achieved because of patients' status, neoadjuvant chemotherapy followed by interval debulking surgery should be considered, although it is still in clinical-trials.
Similar articles
-
[Ovarian cancer treatment from the standpoint of the gynecologic oncologist].Gan To Kagaku Ryoho. 2007 Jul;34(7):1011-6. Gan To Kagaku Ryoho. 2007. PMID: 17637537 Japanese.
-
[Neo-adjuvant chemotherapy followed by interval debulking surgery in advanced ovarian cancer treatment--a retrospective study].Klin Onkol. 2009;22(6):273-7. Klin Onkol. 2009. PMID: 20099745 Slovak.
-
Phase III trial of upfront debulking surgery versus neoadjuvant chemotherapy for stage III/IV ovarian, tubal and peritoneal cancers: Japan Clinical Oncology Group Study JCOG0602.Jpn J Clin Oncol. 2008 Jan;38(1):74-7. doi: 10.1093/jjco/hym145. Jpn J Clin Oncol. 2008. PMID: 18258715 Clinical Trial.
-
[Prognostic factors of ovarian cancer].Gan To Kagaku Ryoho. 2006 Dec;33(13):2014-9. Gan To Kagaku Ryoho. 2006. PMID: 17197745 Review. Japanese.
-
[Ovarian cancer].Gan To Kagaku Ryoho. 2007 Nov;34(11):1735-9. Gan To Kagaku Ryoho. 2007. PMID: 18030006 Review. Japanese.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
